- View the NHLBI Biorepository Guide to Building Biospecimen Collections
- View the NHLBI Biorepository video: NHLBI Biospecimen and Data Repository Program: Advancing Medical Research
Search for Study Datasets and/or Biospecimens
A new open-access paper about BioLINCC metrics and results is now available on PLOS ONE:
Giffen CA, Wagner EL, Adams JT, Hitchcock DM, Welniak LA, Brennan SP, Carroll LE. “Providing researchers with online access to NHLBI biospecimen collections: The results of the first six years of the NHLBI BioLINCC program”.
The Imaging Core Lab of the National Registry of Genetically Triggered Thoracic Aortic Aneurysms (GenTAC) is now considering applications from researchers who have obtained GenTAC data through BioLINCC and who wish to have additional or novel evaluation of GenTAC images beyond the image readings obtained under the original GenTAC study protocol. The application form, instructions, and contact information for the Imaging Core Lab will be made available for request upon approval and fulfillment of a GenTAC data request through BioLINCC.
This funding opportunity is to support meritorious exploratory research relevant to the NHLBI mission using the biospecimen collections that are stored in the NHLBI Biorepository and that are available through BioLINCC. The next application due date is October 17, 2018.
For more information on RFA-HL-17-022 please visit:
The RFA-HL-17-022 funding opportunity now has a FAQ available here: https://www.nhlbi.nih.gov/grants-and-training/funding-opportunities-and-contacts/all-funding-opportunity-announcements-1745
AIDS application due dates have been added to the Funding Opportunity Announcement for RFA-HL-17-022 "Maximizing the Scientific Value of the NHLBI Biorepository: Scientific Opportunities for Exploratory Research (R21)". The next application due date is January 7, 2019.
For more information, please visit: https://grants.nih.gov/grants/guide/notice-files/NOT-HL-17-565.html
This funding opportunity is to stimulate the use of existing human datasets for well-focused secondary analyses to investigate novel scientific ideas or new models, systems, tools, methods, or technologies that have the potential for significant impact on biomedical or biobehavioral research in areas relevant to the NHLBI mission. The next application due date is February 22, 2019.
For more information on PAR-17-004 please visit:
Data have been updated for the Atherosclerosis Risk in Communities Study (ARIC). Now included are v1-v5 examination cycles, collated annual follow-up communication data for contact yea...
A new study, Long-term Oxygen Treatment Trial (LOTT), has been posted to BioLINCC. Data from this study are available for requests.
A new study, Blood and Marrow Clinical Trials Network (BMT CTN) A Phase II Trial of Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation for Patients With Relapsed Follicula...